Mbarara, Uganda – July 4, 2025: The grand opening of the new Faculty of Computing and Informatics building at Mbarara University of Science and Technology (MUST) was not just a celebration of architectural brilliance but also a showcase of groundbreaking innovations. Among the exhibitors was AKOLS, represented by Mr. Emmanuel Maleka Simba, a pharmaceutical analyst, who presented DERMARLIC Tincture, an NDA-Notified (THA 1119) product formulated for managing topical fungal infections and eczema. The event, graced by dignitaries and academic leaders, underscored Uganda’s commitment to STEM excellence and homegrown innovation.
The ceremony was led by Hon. Molly Asiimwe, Head of the Education Committee of Parliament and Woman MP for Rwampara District, who represented the Chief Guest, Rt. Hon. Thomas Tayebwa, the Deputy Speaker of the Parliament of Uganda. In her speech, Hon. Asiimwe lauded the President of the Republic of Uganda, H.E. Yoweri Kaguta Museveni’s visionary leadership, emphasizing that the new facility exemplifies results-driven governance and a commitment to advancing science and technology in Uganda.
Prof. Pauline Byakika-Kibwika, MUST Vice-Chancellor, emphasized the importance of the new building, which replaces a previously dilapidated structure. She reaffirmed MUST’s dedication to promoting innovation, research, and technological progress, providing students and staff with world-class resources to advance Uganda’s digital and scientific development.
AKOLS’ DERMARLIC Tincture: A breakthrough in natural dermatological care
Among the exhibitions, AKOLS stood out with its flagship product, DERMARLIC Tincture, a 100% organic, NDA-Notified formula for the management of fungal infections and eczema. The product, derived from natural antimicrobial and anti-inflammatory compounds, has gained recognition for its effectiveness, safety, and affordability, providing a potent alternative to traditional synthetic treatments.
Visitors, including health professionals, students, and policymakers, examined the science behind DERMARLIC Tincture. The enthusiastic reception reaffirmed the increasing demand for locally produced, certified organic healthcare solutions that target common skin conditions in Uganda and beyond.
AKOLS: Pioneering Ugandan Health Innovation
The exhibition at MUST’s FCI building grand opening was more than just a product showcase; it was evidence of Uganda’s potential in biotech and pharmaceutical innovation. AKOLS continues to steer the wheel in research-driven natural remedies, aligning with MUST’s mission to bridge academia and industry for real-world impact.
As Uganda strides toward scientific self-reliance, partnerships between universities and innovators like AKOLS amongst others are indeed crucial in shaping a healthier, more technologically advanced future.
Together, let’s embrace science, sustainability, and Ugandan excellence!